Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2003
09/16/2003US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders
09/16/2003US6620605 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
09/16/2003US6620596 Reacting glyoxal-guanine with ribose-1-phosphate or 2-deoxyribose-1-phosphate in the presence of purine nucleoside phosphorylase; decomposition with an alkali to produce guanosine or 2*-deoxyguanosine; efficiency
09/16/2003US6620594 Uncoupling protein homologue: UCP 3
09/16/2003US6620592 Nucleotide sequences coding enzymatic polypeptides; for use in treatment of defects in cell proliferation and immunological response; for use prevention and treatment of stroke and alzheimer's disease; antiischemic agents
09/16/2003CA2261151C Transformation of pichia methanolica
09/16/2003CA2250174C Test media and quantitative method for identification and differentiation of biological materials in a test sample
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/16/2003CA2054590C Novel cyclosporins
09/12/2003WO2003074721A2 Method for producing riboflavin
09/12/2003WO2003074719A2 Amino acid-producing bacteria and a process for preparing l-amino acids
09/12/2003WO2003074705A1 Proteins capable of binding to environmental hormones and process for producing the same
09/12/2003WO2003074704A1 Proteins capable of binding to female sex hormones and process for producing the same
09/12/2003WO2003074703A1 Novel transcriptional factor, dna thereof and use of the same
09/12/2003WO2003074700A2 Transposon
09/12/2003WO2003074697A1 Method of modifying protein properties
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074690A1 Amino acid racemase having low substrate specificity and process for producing racemic amino acid
09/12/2003WO2003074682A1 Bacterial spores
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074676A2 Wax ester synthase dna sequence, protein and uses thereof
09/12/2003WO2003074657A2 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003WO2003074559A1 Falp proteins
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074004A2 Method of producing antigens
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003073828A2 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003054168A3 Defined competitive exclusion cultures for food borne pathogens
09/12/2003WO2003048364A3 Ovomucoid promoter and methods of use
09/12/2003WO2003039260A3 Probiotic compositions
09/12/2003WO2003031579A3 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
09/12/2003WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same
09/12/2003WO2003006663A3 Method for producing deletion mutants
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002058727A3 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002042461A3 Endogenous and non-endogenous versions of human g protein-coupled receptors
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
09/12/2003WO2002010355A3 Alpha-amylase mutants with altered stability
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2478266A1 Amino acid-producing bacteria and a process for preparing l-amino acids
09/12/2003CA2477969A1 Falp proteins
09/12/2003CA2477856A1 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003CA2477849A1 Method for producing riboflavin
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477406A1 Dna vaccine against proliferating endothelial cells and methods of use thereof
09/11/2003WO2003073995A2 Dna vaccine against proliferating endothelial cells and methods of use thereof.
09/11/2003US20030172397 Papaya ringspot virus genes
09/11/2003US20030172391 A transgenic mouse; the enzyme for treating inflammation, smooth muscle contraction; animal models
09/11/2003US20030171567 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
09/11/2003US20030171564 Novel argS
09/11/2003US20030171560 Filtering through a semipermeable membranes, only low molecular weight with small diameter can pass through
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171544 A novel alcohol dehydrogenase (ADHF1) from Pseudomonas fluorescens (DSM 50106) and to functional variants and to a process for enantiomorphic reduction of ketones to the corresponding alcohols by using such alcohol dehydrogenases
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171317 Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
09/11/2003US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171275 Transporters and ion channels
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171269 Novel epidermal growth factor protein and gene, and methods of use therefor
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030171254 Purified outer membrane protein of a Moraxella strain, particularly M. catarrhalis, having a molecular mass of about 200 kDa, is provided. The about 200 kDa outer membrane protein as well as nucleic acid molecules encoding the same are useful
09/11/2003US20030171236 Alpha-amylase mutants
09/11/2003US20030171235 Subtilase enzymes
09/11/2003US20030170900 Deactivating and deleting a characteristic gene defining a detectable host characteristic and inserting a DNA fragment of interest into the modified host together with intact characteristic gene enabling confirmation of integration
09/11/2003US20030170899 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
09/11/2003US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products
09/11/2003US20030170895 Methods of making hypermutable cells using PMSR homologs
09/11/2003US20030170877 Using gene from Ralstonia eutropha strain TB64; bioremediation
09/11/2003US20030170876 Methods for producing a polypeptide in a bacillus cell
09/11/2003US20030170874 Treating liquid hydrocarbons with members of genus Alcaligenes which transform organic sulfur-containing compounds into inorganic sulfur compounds
09/11/2003US20030170873 By using members of genus Alcaligenes which transforms organic sulfur-containing compounds into inorganic sulfur compounds
09/11/2003US20030170865 Novel polypeptide of protein p140 and DNAs encoding it
09/11/2003US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170860 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170854 Recombinant human creatine kinase heterodimer with solution-stability
09/11/2003US20030170847 Genes involved in isoprenoid compound production
09/11/2003US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
09/11/2003US20030170837 Hydrolyzing hydroxyvaleronitrile with nitrile hydratase/ nitrilase and amidase to form 3-hydroxyvaleric acid; for production of polycaprolactone
09/11/2003US20030170834 Fungi/bacteria convert cinnamate/glucose/tyrosine to para-hydroxycinnamic acid via phenylalanine ammonia-lyase (PAL)/tyrosine ammonia-lyase
09/11/2003US20030170833 Prenyltransferases; soybean proteins; improving plant growth
09/11/2003US20030170831 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
09/11/2003US20030170830 Glucans; from Microdochium nivale cultures; freeze drying
09/11/2003US20030170825 Comprises antihemophilic factor (factor VIII) and antitrypsin signal sequences; for treatment of hemophilia
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 1489